ClinicalTrials.gg
CompletedNCT02385344REQUESTUpdated Sep 7, 2018

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery

An observational study in Coronary Artery Bypass, sponsored by Medistim ASA. Completed at 7 sites in 6 countries. Per ClinicalTrials.gov, last updated 2018-09-07.

Sponsored by Medistim ASA · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,046
Sex
All
01

Study summary

The purpose of the registry is to collect information regarding the number and type of coronary artery bypass (CAB) surgical procedure changes that are made based on intraoperative guidance information using transit time flow measurements (TTFM) and ultrasound image capabilities provided with the Medistim device.

02

Conditions studied

  • Coronary Artery Bypass
03

In context

Lead sponsor

Medistim ASA is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subject has been scheduled for coronary bypass surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject has been scheduled for coronary bypass surgery
  • Subject understands the nature of the procedure and has signed the subject prior to the procedure
  • Subject has been diagnosed with 2-3 vessel disease

Exclusion criteria

Exclusion Criteria:

  • Subject is scheduled for other surgical procedures during the bypass surgery (valve replacement/repair, carotid endarterectomy, etc.)
  • Subject is known to be suffering from any psychological, developmental, physical, or emotional disorder that the investigator feels would interfere with surgery or follow-up testing
  • Subject is undergoing an emergency cardiac bypass surgery
  • Subject has history or presence of muscle disease (i.e. myopathy, myalgia, myasthenia, rhabdomyolysis) with or without concomitant CK-elevation > 5 that cannot be ascribed to any other medical condition (e.g. myocardial infarction)
  • Subject has any condition that the investigator believes should exclude him/her from this registry
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ULN (upper limit of normal)

The top of the normal range for a blood test, as set by the laboratory that runs it. Each lab prints its own range next to your result.

“≤ 2.5 × ULN” means the result can be up to two and a half times that top value.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,046 participants (actual)
Target follow-up
2 Weeks
Patient registry
Yes

Interventions

  • DeviceMedistim device

    This registry is intended to document surgical findings, procedural changes, and adverse events occurring prior to discharge

06

What researchers measure

Primary outcomes

  1. Change in planned surgical procedure

    Identify how often epiaortic scanning With the Medistim Device, leads to a change in the planned surgical procedure and to identify the reason and the procedure change

    Time frame: Day 1 (During Surgery)

  2. Procedure adaptions

    Identify the procedure adaptions made by a surgeon when TTFM and/or Medistim ultrasound imaging identify suboptimal graft function

    Time frame: Day 1 (During surgery)

Secondary outcomes

  1. Record number of revisions

    Record how many Cardiac bypass patients experience intraoperative graft revision, the type of revision, and the key identifier motivating the revision

    Time frame: Day 1 (During surgery)

  2. Record number of events

    Record post-surgical major adverse cardiac and cerebral events (MACCE) of all bypass procedure patients entered into the registry and occuring prior to discharge

    Time frame: Day 1-14 (During hospitalization)

  3. Incidence rate

    To determine the incidence rate of Serious Adverse Events (SAE) and/or Unanticipated Adverse Events (UAE) throughout the registry

    Time frame: 2 years (Throughout the study)

07

Study locations

7 sites
  • Veterans Affairs Medical Center
    Washington DC, Maryland 20422, United States
  • Mount Sinai Beth Israel
    New York, New York 10003, United States
  • University of Calgary
    Calgary, Alberta AB T2N 1N4, Canada
  • University of Duisburg-Essen, Dept. of Cardiothoracic Surgery
    Essen, 45122, Germany
  • Clinica Cardiochirurgica
    Chieti, 66100, Italy
  • Erasmus University Medical Center
    Rotterdam, 3015 GD, Netherlands
  • University of Oxford
    Oxford, OX3 9DU, United Kingdom
08

References and documents

Publications

  • Leviner DB, von Mucke Similon M, Rosati CM, Amabile A, Thuijs DJFM, Giammarco GD, Wendt D, Trachiotis GD, Kieser TM, Kappetein AP, Head SJ, Taggart DP, Puskas JD. Transit time flow measurement of coronary bypass grafts before and after protamine administration. J Cardiothorac Surg. 2021 Jul 9;16(1):195. doi: 10.1186/s13019-021-01575-y. PubMed 34243799 ↗
  • Rosenfeld ES, Trachiotis GD, Napolitano MA, Sparks AD, Wendt D, Kieser TM, Puskas JD, DiGiammarco G, Taggart DP. Intraoperative transit-time flow measurement and high-frequency ultrasound in coronary artery bypass grafting: impact in off versus on-pump, arterial versus venous grafting and cardiac territory grafted. Eur J Cardiothorac Surg. 2021 Dec 27;61(1):204-213. doi: 10.1093/ejcts/ezab239. PubMed 34166508 ↗
  • Rosenfeld ES, Trachiotis GD, Sparks AD, Napolitano MA, Lee KB, Wendt D, Kieser TM, Puskas JD, DiGiammarco G, Taggart DP. Intraoperative surgical strategy changes in patients with chronic and end-stage renal disease undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1210-1217. doi: 10.1093/ejcts/ezab104. PubMed 33675642 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2015, a primary completion of Dec 2017 and a completion of Dec 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2015
First posted
Mar 11, 2015
Start
Apr 2015
Primary completionActual
Dec 2017
CompletionActual
Dec 2017
Last update
Sep 7, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02385344
Lead sponsor
Medistim ASA
Responsible party
Sponsor
First posted
Mar 11, 2015
Start date
Apr 2015
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Sep 7, 2018

Study contacts

Anne Waaler, MSc Pharm
study director · Medistim ASA

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion